Covered recipient · General Payments record
ZARAR M BAJWA
Allopathic & Osteopathic Physicians Pediatrics
General Payments · PY2018–2024
$1,558.67
- Reported across 90 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $182.10 | 10 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $51.54 | 2 |
| GlaxoSmithKline, LLC. | $36.44 | 2 |
| SANOFI-AVENTIS U.S. LLC | $30.59 | 2 |
| Cranial Technologies, Inc | $24.98 | 2 |
| Electromed, Inc. | $19.68 | 1 |
| PFIZER INC. | $18.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (10)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Cranial Technologies, Inc | $11.80 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082220368 | CMS |
| Cranial Technologies, Inc | $13.18 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1082220370 | CMS |
| Electromed, Inc. | $19.68 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137878922 | CMS |
| GlaxoSmithKline, LLC. | $20.50 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116541246 | CMS |
| GlaxoSmithKline, LLC. | $15.94 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116465046 | CMS |
| Merck Sharp & Dohme LLC | $26.26 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141952785 | CMS |
| Merck Sharp & Dohme LLC | $25.28 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141819063 | CMS |
| PFIZER INC. | $18.87 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131925970 | CMS |
| SANOFI-AVENTIS U.S. LLC | $13.37 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139667878 | CMS |
| SANOFI-AVENTIS U.S. LLC | $17.22 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139667870 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.